Research

Female cancer patient receiving chemotherapy

Adoptive Immunotherapy is Being Studied in Ovarian Cancer

Trial examines novel approach for a disease with a high mortality rate

Tick
May 25, 2021/Pathology/Research

Characterizing Patient Immune Responses to Emerging Tick-borne Virus

Researchers have developed immunoprofiles for an emerging disease with a mortality rate as high as 27%

18-PTH-1114-INSM1-composite-650×450
March 19, 2018/Pathology/Research

A New Marker for Neuroendocrine Lung Tumors: INSM1

Largest series shows marker sensitive, highly specific

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

BackPage 1 of 1Next

Advertisement

Ad